SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-020159
Filing Date
2021-08-16
Accepted
2021-08-16 16:06:32
Documents
15
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210813_8k.htm   iXBRL 8-K 27020
2 EXHIBIT 99.1 ex_275917.htm EX-99.1 183970
7 arx01.jpg GRAPHIC 6810
  Complete submission text file 0001437749-21-020159.txt   373791

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210816.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210816_def.xml EX-101.DEF 11808
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210816_lab.xml EX-101.LAB 15859
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210816_pre.xml EX-101.PRE 12023
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210813_8k_htm.xml XML 2659
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 211177996
SIC: 2834 Pharmaceutical Preparations